Successful isolated limb revascularization through the deep femoral artery in a patient with a high risk of amputation (case report)
AbstractThis clinical case demonstrates an example of successful isolated repeat revascularization of the deep femoral artery using surgical and endovascular methods in a patient with rapidly progressive atherosclerosis and renal failure. Multiple attempts at direct revascularization for critical limb ischemia of the collateral lower limb for less than 2 years had resulted in amputation at the level of the thigh. With the development of critical ischemia of the contralateral limb, the tactics of indirect restoration of blood flow through the deep femoral artery made it possible to achieve regression of critical ischemia and save the limb. We consider it expedient to perform surgical treatment in patients with widespread atherosclerotic lesions of the distal segment, starting with isolated revascularization of the limb through the deep femoral artery.
Funding. Research support: grant of the Ministry of Education and Science No. 075-15-2022-1110.
Conflict of interest. The authors declare no conflicts of interest.
Authors’ contribution. Study conception and design – Gamzatov T.Kh., Kebriakov A.V., Svetlikov A.V.; data collection and handling – Kebriakov A.V.; draft manuscript preparation – Kebriakov A.V.; manuscript revision – Svetlikov A.V., Kashchenko V.A., Ratnikov V.A., Gurevich V.S.
For citation: Gamzatov T.Kh., Kebriakov A.V., Svetlikov A.V., Kashchenko V.A., Ratnikov V.A., Gurevich V.S. Successful isolated limb revascularization through the deep femoral artery in a patient with a high risk of amputation (case report). Angiology and Vascular Surgery. Journal named after Academician A.V. Pokrovsky. 2023; 29 (3): 38–45. DOI: https://doi.org/10.33029/1027-6661-2023-29-3-38-45 (in Russian)
Keywords: critical limb ischemia; revascularization; femoroprofundoplasty; balloon angioplasty of the deep femoral artery
References
1. Gamzatov T.H., Svetlikov A.V. The modern principles of management of intermittent claudication. Pirogov Russian Journal of Surgery. 2016; 12: 77–87. DOI: https://doi.org/10.17116/hirurgia20161277–87 (in Russian)
2. Elsharkawi M., Elkassaby M., McVeigh N., et al. Clinical outcomes from profundoplasty performed as a sole procedure for revascularization in critically ischaemic limbs. Vascular. 2021; 29 (3): 396–403. DOI: https://doi.org/10.1177/1708538120963901
3. Savolainen H., Hansen A., Diehm N., et al. Small is beautiful: why profundaplasty should not be forgotten. World Journal of Surgery. 2007; 31 (10): 2058–2061. DOI: https://doi.org/10.1007/s00268-007-9188-y
4. Ye M., Lin W., Zheng J., Lin S. N-acetylcysteine for chronic kidney disease: a systematic review and meta-analysis. American Journal of Translational Research. 2021; 13 (4): 2472–2485.
5. Svetlikov A.V., Ishpulaeva L.E. Modern strategy to improve remote results of surgical treatment of peripheral artery disease. Angiology and Vascular Surgery. 2020; 26 (4): 23–31. DOI: https://doi.org/10.33529/ANGIO2020423 (in Russian)
6. Kashchenko V.A., Ratnikov V.A., Vasiukova E.L., et al. Hematomas of different localizations in patients with COVID-19. Endoscopic Surgery. 2021; 27 (6): 5–13. DOI: https://doi.org/10.17116/endoskop2021270615 (in Russian)
7. Trenner M., Patelis N., Bartos O.; EL-COVID collaborators. Vascular education through e-Learning. Vasa. 2022; 51 (5): 291–297. DOI: https://doi.org/10.1024/0301-1526/a001020
8. Shapovalov A.S., Kebriakov A.V., Gamzatov T.K., et al. The management of COVID-associated thrombosis by local arterial thrombolysis. Regional Blood Circulation and Microcirculation. 2022; 21 (2): 80–85. DOI: https://doi.org/10.24884/1682-6655-2022-21-2-80-85 (in Russian)
9. Ravikumar N., Sreejith G., Law S.H.C., et al. Comparative Analysis of Endovascular Intervention and Endarterectomy in Patients with Femoral Artery Disease: A Systematic Review and Meta-Analysis. Hematology Reports. 2022; 14 (2): 179–202. DOI: https://doi.org/10.3390/hematolrep14020026
10. Bath J., Avgerinos E. A pooled analysis of common femoral and profunda femoris endovascular interventions. Vascular. 2016; 24 (4): 404–413. DOI: https://doi.org/10.1177/1708538115604929
11. Kuo T.T., Chen P.L., Huang C.Y., et al. Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease. Journal of Vascular Surgery. 2019; 69 (1): 141–147. DOI: https://doi.org/10.1016/j.jvs.2018.05.225
12. Donas K.P., Pitoulias G.A., Schwindt A., et al. Endovascular treatment of profunda femoris artery obstructive disease: nonsense or useful tool in selected cases? European Journal of Vascular and Endovascular Surgery. 2010; 39 (3): 308–313. DOI: https://doi.org/10.1016/j.ejvs.2009.10.008
13. Varty K., London N.J., Ratliff D.A., et al. Percutaneous angioplasty of the profunda femoris artery: a safe and effective endovascular technique. European Journal of Vascular and Endovascular Surgery. 1993; 7 (5): 483–487. DOI: https://doi.org/10.1016/s0950-821x(05)80357-3
14. Silva J.A., White C.J., Ramee S.R., et al. Percutaneous profundaplasty in the treatment of lower extremity ischemia: results of long-term surveillance. Journal of Endovascular Therapy. 2001; 8 (1): 75–82. DOI: https://doi.org/152660280100800113
15. Imran H.M., Hyder O.N., Soukas P.A. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease. Cardiovascular Revascularization Medicine. 2019; 20 (3): 210–214. DOI: https://doi.org/10.1016/j.carrev.2018.06.018
16. Schroeder H., Meyer D.R., Lux B., et al. A Pilot Study of Femoropopliteal Artery Revascularisation with a Low Dose Paclitaxel Coated Balloon: Is Predilatation Necessary? European Journal of Vascular and Endovascular Surgery. 2017; 54 (3): 348–355. DOI: https://doi.org/10.1016/j.ejvs.2017.06.020
17. Tepe G., Laird J., Schneider P., et al.; IN.PACT SFA Trial Investigators. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation. 2015; 131 (5): 495–502. DOI: https://doi.org/CIRCULATIONAHA.114.011004
18. Rosenfield K., Jaff M.R., White C.J., et al.; LEVANT 2 Investigators. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. New England Journal of Medicine. 2015; 373 (2): 145–53. DOI: https://doi.org/10.1056/NEJMoa1406235
19. Werk M., Albrecht T., Meyer D.R., et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circulation: Cardiovascular Interventions. 2012; 5 (6): 831–840. DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.112.971630
20. Tepe G., Zeller T., Albrecht T., et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. New England Journal of Medicine. 2008; 358 (7): 689–699. DOI: https://doi.org/10.1161/10.1056/NEJMoa070635
21. Werk M., Langner S., Reinkensmeier B., et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008; 118 (13): 1358–1365. DOI: https://doi.org/10.1161/CIRCULATIONAHA.107.735985
22. Mouawad N.J. Is isolated profundoplasty enough in critical limb ischemia? Vascular. 2022; 30 (1): 183–184. DOI: https://doi.org/10.1177/1708538121991265
23. Kebriakov A.V., Svetlikov A.V., Gamzatov T.K., et al. Isolated deep femoral artery plasty in the management of peripheral arterial disease. Regional Blood Circulation and Microcirculation. 2022; 21 (3): 12–19. DOI: https://doi.org/10.24884/1682-6655-2022-21-3-12-19 (in Russian)
24. Dick P., Mlekusch W., Sabeti S., et al. Outcome after endovascular treatment of deep femoral artery stenosis: results in a consecutive patient series and systematic review of the literature. Journal of Endovascular Therapy. 2006; 13 (2): 221–228. DOI: https://doi.org/10.1583/05-1766R.1
25. Balasundaram N., Whitrock J.N., Braet D.J., et al. Importance
of the profunda femoris upon patency following aortoiliac procedures. Journal of Vascular Surgery. 2022; 76 (1): 180–187. DOI: https://doi.org/10.1016/j.jvs.2022.02.043
All articles in our journal are distributed under the CC BY-NC-ND 4.0 (Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International)
п?? GEOTAR-Media Publishing Group. The use of textual and illustrative content from this publication for the training of any artificial intelligence systems п?? including machine learning models and neural networks п?? is strictly prohibited without the prior written consent of the copyright holder.